Information source: Jia Yifang from Eugenic Genetics Department Photography: Zhang Haifeng Released on: December 29, 2021

　　On December 23, the Multidisciplinary Diagnosis and Treatment Center for Hypophosphatemic Rickets/Osteomalacia of Shandong Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital) was officially established to provide integrated diagnosis, treatment and medical management for patients with HR/osteomalacia nationwide. This first multidisciplinary diagnosis and treatment center for HR/osteomalacia in China fills the gap in domestic field of integrated diagnosis and treatment. It marks that Shandong Provincial Hospital has taken another important step in rare disease, promotes the development of rare disease discipline in Shandong province, and improves the diagnosis and treatment of rare diseases. Zhao Jiajun, President of Shandong Provincial Hospital, Wang Rong, Member of Party Committee and Vice President of the hospital attended the inaugural ceremony.

Inaugural ceremony of multidisciplinary diagnosis and treatment center for hypophosphatemic rickets/osteomalacia in Shandong Provincial Hospital

　　President Zhao Jiajun pointed out that, in recent years, the government has paid more attention to the group of patients with rare diseases. Shandong Provincial Hospital has put in place national policy requirements, facilitated a lot of work on health education and popular science publicity, carried out screening, early diagnosis and treatment, and improved the public awareness of diseases. The hospital has actively integrated the resources of strong disciplines, continuously explored, carried out and improved the diagnosis and treatment of rare diseases, strengthened the cooperation between relevant departments and all sectors of society, and promoted the establishment of rare disease discipline in Shandong Province to lead the high-quality development of rare disease treatment.

　　Vice President Wang Rong said that, relying on the strong medical resources of the hospital and rich experience in the diagnosis and treatment of rare diseases, MDT for HR brings together top experts from various disciplines, plays an important role in patient screening, MDT clinics, diagnosis and treatment of HR and academic discussion. The center provides individualized and one-stop diagnosis and treatment model for patients with HR, offers patients higher quality services and promotes the modern precision medicine level in the province.

　　Rare diseases are a large group of diseases with a very low incidence and they are mostly hereditary. Although the number of patients is small, there are many kinds of rare diseases, most of which are hereditary, with different clinical symptoms and pathogenic mechanisms. At present, there are more than 7000 kinds of rare diseases recognized internationally. HR is a group of rare diseases characterized by hypophosphatemia, which is caused by increased renal phosphorus excretion due to congenital or acquired causes. It has a high rate of disability and teratogenicity, and is listed No.51in the first Rare Diseases Catalogue.

　　HR involves cooperation from many departments and requires a combination of medical and surgical treatment. As the leading institution of the National Rare Disease Diagnosis and Treatment Collaboration Network in Shandong province, Shandong Provincial Hospital took the lead in setting up a multidisciplinary diagnosis and treatment center for HR in China. The center is chaired by the endocrine team with President Zhao Jiajun as leader. The team includes Wang Yanzhou, Chief Surgeon of Pediatric Orthopedic Surgery, Xu Chao, Chief Physician of Endocrinology, Jia Yifang, Chief Physicians of Genetics, Li Guimei，Chief Physicians of Pediatric Endocrinology and Sun Yan, Deputy Chief Physicians of Pediatric Endocrinology who can cooperate and formulate scientific consultation opinions according to the patient condition and treatment effect to provide medical services.

　　Multidisciplinary integrated diagnosis and treatment can overcome the deficiency of single discipline diagnosis and treatment, and comprehensively make the most effective and feasible treatment plan based on the results of biochemical examination, genetic examination, imaging evaluation of patients and multidisciplinary consultation. So patients can avoid visiting doctors from multiple departments.